Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

South Carolina

Phase 1 cancer trials in South Carolina

35 Phase 1 cancer studies are recruiting participants at sites in 5 cities across South Carolina as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every South Carolina city with a recruiting study

By research area: Prostate Cancer (13), Breast Cancer (8), Lung Cancer (7), Lymphoma (7).

Charleston (14), Greenville (13), Myrtle Beach (12), Columbia (1), Spartanburg (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in South Carolina

Basic details from each study's public record (the 12 most recently updated of 35). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Greenville
    Registry record
    NCT06686394 · updated
  2. Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    ORIC Pharmaceuticals
    Recruiting in
    Spartanburg
    Registry record
    NCT05315700 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in South Carolina on ClinicalTrials.gov.

Lung cancer: recently updated in South Carolina

  1. A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Myrtle Beach
    Registry record
    NCT03460977 · updated
  2. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SystImmune Inc.
    Recruiting in
    Greenville
    Registry record
    NCT07080242 · updated
  3. A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    DualityBio Inc.
    Recruiting in
    Charleston · Greenville
    Registry record
    NCT05914116 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in South Carolina on ClinicalTrials.gov.

Prostate cancer: recently updated in South Carolina

  1. TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    Novartis Pharmaceuticals
    Recruiting in
    Charleston · Myrtle Beach
    Registry record
    NCT07190300 · updated
  2. Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Recruiting in
    Myrtle Beach
    Registry record
    NCT06800313 · updated
  3. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    • Phase 1
    • Ages 18 to 100
    • Male participants
    Sponsor
    Janux Therapeutics
    Recruiting in
    Charleston
    Registry record
    NCT05519449 · updated
  4. A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Daiichi Sankyo
    Recruiting in
    Myrtle Beach
    Registry record
    NCT07244341 · updated
  5. Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

    • Phase 1/2
    • Ages 18 to 130
    • Male participants
    Sponsor
    AstraZeneca
    Recruiting in
    Myrtle Beach
    Registry record
    NCT07181161 · updated
  6. A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    K36 Therapeutics, Inc.
    Recruiting in
    Myrtle Beach
    Registry record
    NCT07103018 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in South Carolina on ClinicalTrials.gov.

Ask about studies in South Carolina

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call